An Overview of the Practice-Changing Information From the 2013 ASCO Meeting
Sandra Swain, MD, from the Washington Cancer Institute at MedStar Washington Hospital Center, on the practice-changing information from the 2013 ASCO Meeting.
Sandra Swain, MD, medical director of the Washington Cancer Institute at MedStar Washington Hospital Center, gives an overview of the practice-changing information from the 2013 American Society of Clinical Oncology (ASCO) Meeting.
Swain mentions a trial in stage I seminoma, which showed that radiation or chemotherapy is not necessary after surgery. In a breast cancer trial, there is not a need for an axillary nodal dissection after a positive sentinel node biopsy. Radiation is as effective in this setting as axillary dissection.
Swain highlights another study that found that fitness among middle-aged men can decrease cancer incidence and improve survival.
<<<
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
